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Abstract.  Astroglial cells play an important role in 
orchestrating the migration  and positioning of neurons 
during central nervous system development.  Primary 
astroglia,  as well as astrocytoma cells will extend long 
stable processes when co-cultured with granule neu- 
rons. In order to determine the function of the glial 
fibrillary acidic protein (GFAP), the major intermedi- 
ate filament protein in astroglia and astrocytoma cells, 
we suppressed the expression of GFAP by stable trans- 
fection of an anti-sense GFAP construct in human as- 
trocytoma U251MG cells. The resulting AS2-U251 
cells can no longer extend stable processes in the 
presence of granule neurons.  To show that this effect 
is due specifically to the absence of GFAP,  we rein- 
troduced a fully encoding rat brain GFAP eDNA into 
these AS2-U251 cells.  The resulting rat GFAP ap- 
peared as a filamentous network and the reexpression 
of GFAP rescued the ability of these astrocytoma cells 
to form stable processes when co-cultured with neu- 
rons.  From these results, it is clear that the glial 
specific intermediate filament protein,  GFAP,  is re- 
quired for process extension of these astrocytoma cells 
in response to granule neurons. 
N 
'EURON-GLIA interactions are important for neuronal 
migration  (Rakic,  1971; Rakic and Sidman,  1973; 
Sidman and Rakic,  1973; Levitt and Rakic,  1980), 
neurite outgrowth  (TomaseUi et al.,  1988), and axon guid- 
ance  (Silver  et  al.,  1982)  in  the  developing  mammalian 
brain.  In the mouse cerebellum, postmitotic granule cells 
leave the external granule cell layer during the first two post- 
natal weeks and descend into the internal  granule cell layer 
by migrating along the fibers of Bergmann glia (Sidman and 
Rakic, 1973; Rakic and Sidman,  1973; Rakic, 1971; Gao and 
Hatten,  1993). By using an in vitro microwell  culture sys- 
tem, Hatten and co-workers showed that,  in the presence of 
granule  cells,  astroglial  cells differentiate  into  elongated, 
radial  forms which resemble the glial forms that have been 
shown to support neuronal migration  in brain (Hatten et al., 
1984;  Hatten,  1985, 1987; Mason et al.,  1988).  Granule 
neurons  can  be demonstrated  to  move along  these glial 
processes in vitro (Hatten,  1990; Edmondson and Hatten, 
1987; Hatten and Mason, 1990) with a morphology similar 
to those described in vivo (Rakic,  1971; Rakic et al., 1974). 
The  neurons  tightly  appose  their  soma  along  the  glial 
processes and  extend  a  thickened  leading  process in  the 
direction  of migration  (Edmondson and Hatten,  1987; Hat- 
ten and Mason,  1990).  Similar  migratory behaviors  have 
also been demonstrated with both large and small hippocam- 
pal neurons (Gasser and Hatten, 1990a).  In vivo studies on 
axonal guidance in the optic nerve (Bovolenta et al.,  1987; 
Williams  and Rakic,  1985) and in the white matter of the 
cerebellum (Pinto-Lord et al., 1982) also demonstrated that 
astroglia  intercalate  with growing  axons.  The navigational 
instruction  for migration  seems to be encoded in the neu- 
rons,  not  astroglia,  since  neurons  from  different  brain 
regions  migrate  freely on heterotypic astroglial  cells.  The 
mode of migration,  neuron-glia relationship,  and dynamics 
and speed of  movement of the neurons show no demonstrable 
differences  (Gasser and Hatten,  1990b). 
Like neuronal  processes, astrocytic  processes are tipped 
by a growth cone-like structure (Mason et al., 1988). How- 
ever, whereas the neuronal  growth cones extend in the ab- 
sence of cell-cellcontacts, true glial process extension  (in 
contrast to cavitation  of flattened processes) appears to de- 
pend on the formation  of cell-cell contacts with neurons 
(Mason et al., 1988; Hatten, 1985, 1987; Hatten et al., 1986; 
Edmondson et al.,  1988;  Weinstein  et al.,  1990;  Torres- 
Aleman et al., 1992). Another distinction  between growing 
glial and neuronal processes is the abundance of intermedi- 
ate filaments in the extending glial processes, and their rela- 
tive paucity in  neuronal  processes (Mason et al.,  1988). 
Glial  fibrillary  acidic  protein  (GFAP), t the major protein 
constituent  of glial  intermediate  filaments,  is found in the 
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immunoelectron microscopy. 
To determine if GFAP is central to any of these changes, 
we previously suppressed the expression of GFAP in U251MG 
cells,  a  permanent human astrocytoma cell line  (Wester- 
mark,  1973), by transfection with an expression construct 
constitutively transcribing the anti-sense strand of a murine 
GFAP cDNA (Weinstein et al.,  1991).  The results showed 
that, with the suppression of GFAP expression, these AS2- 
U251MG ceils were unable to extend complex processes in 
response to neurons. Other cytoskeletal components such as 
vimentin and the micmtubule-associated protein,  MAP4, 
were not affected and formed normal filamentous networks. 
These results suggested that GFAP is required for glial pro- 
cess formation in the presence of neurons. 
In this study, we have isolated a fully encoding rat GFAP 
cDNA clone and used it to reexpress GFAP in the GFAP- 
suppressed, AS2-U251 cells (Weinstein et al.,  1991).  Our 
results show that, after re.expression of GFAP, these cells re- 
gain the ability to extend processes when co-cultured with 
granule neurons. 
Materials and Methods 
Antibodies 
Polyclonal anti-GFAP antibody (pAb-GFAP) is a rabbit antiserum (Wang 
et al.,  1984), used at a dilution of 1:200.  G-A-5, a monoclonal anti-GFAP 
antibody used in double labeling experiments at a dilution of 1:250,  was 
obtained  from  Sigma Chemical  Co.  (St.  Louis,  MO).  Polyclonal anti- 
microtubule-associated protein 4 antiserum, LHB (pAb-MAP4), a kind gift 
of Dr. J. C. Bulinski (Columbia University, New York), is a polyclonal rab- 
bit antiserum that  specifically  recognizes primate  MAP4  (Bulinski and 
Borisy, 1980). This anti-MAP4 antiserum allowed us to stain only the hu- 
man astrocytoma cells without interference from the small number of rat 
astrocytes contaminating our preparations of neurons. Goat anti-rabbit and 
anti-mouse IgG's conjugated to either FITC or TRITC were purchased from 
Organon Teknika Corp.  (Charlotte, NC). 
Screening of  Rat Brain cDNA Library 
A 2-kb fragment of murine GFAP cDNA (Lewis et al.,  1984), a kind gift 
from Dr. N. J. Cowan (Department of Biochemistry, New York University, 
New York), was used to screen an amplified rat brain )~-gtl 1 cDNA expres- 
sion library (generously provided by Dr. D. Coiman, Mt. Sinai University, 
New York), following procedures described previously (Napolitano et al., 
1987;  Chin and Liem,  1990). 
In Vitro Transcription and Translation 
The GFAP cDNA-containing clone CO2 was digested with EcoRI and the 
resulting insert fragment was subcloned into pGEM-TZf (Promega Biotec, 
Madison, WI), which had been previously digested with EcoRI and treated 
with calf intestine phosphatase (Boehringer Mannheim Biochemicals, Indi- 
anapolis,  IN).  In vitro-synthesized transcripts of the resulting plasmid, 
pGEM7Zf-G92, were generated by either T7 or SP6 RNA polymerases ac- 
cording to the protocol suggested by Riboprobe Gemini System (Melton et 
al.,  1984). Briefly, 5 #g of plasmid was mixed with appropriate concentra- 
tions of transcription buffer,  DTT,  CAP,  RNAsin,  and either T7 or SP6 
polymerase and incubated in 37°C for 1 h. These RNA transcripts were then 
translated in a rabbit reticulocyte lysate system (New England Nuclear, Wil- 
mington, DE) following the protocol reconunonded by the manufacturer. 
In brief, the RNA transcripts were mixed with [?SS]methionine, potassium 
acetate, magnesium acetate, and translation cocktail provided by manufac- 
turer, and incubated in 37°C for 1 h. The resulting product was separated 
by SDS-PAGE followed by autoradiography. 
DNA Sequencing 
The GFAP cDNA clone (CO2) was subcloned, in both orientations, into the 
unique EcoRI site of bacteriophage M13mplS. Sequentially shorter, over- 
lapping subclones in both orientations were created by the rapid deletion 
method developed by Dale et al. (1985), using T4 DNA polymerase pur- 
chased from Promega Biotec. The terminal deoxyribonuclcotidyl transfer- 
ase and subcloning primer, RD29-mer, were purchased from IBI-A Kodak 
Co.  (New Haven, CT). DNA sequencing was performed according to the 
dideoxy  chain termination sequencing  protocol  by  Sanger et al.  (1980) 
but using  Seqnenase  v.2.0  (UBS,  Cleveland,  OH)  and deoxyadenosine 
5'-(et-35S-thio) triphosphate (New England Nuclear). 
Sequence Analysis 
Nucleotide and amino acid sequences were analyzed using the DNA/Pro- 
tein Sequence Analysis System software developed by James M. Pustell and 
IBI (Pustell and Kafatos,  1984). 
Construction of GFAP Expression Vectors 
The  2.7-kb  rat  GFAP  cDNA  insert  was  isolated  by  digestion  of  the 
pGEM7Zf-G92 plasmid with EcoRI. After gel purification, this fragment 
was blunt-ended with the large Klenow fragment of Escherichia coli DNA 
polymerase I and ligated with HindIII linkers (Boehringer Mannheim Bio- 
chemicals)  freshly  phosphorylated  by  T4  polynucleotide  kinase.  After 
digestion with excess HindIII and gel purification, the GFAP-encoding frag- 
ment was cloned into the unique HindIII site of the expression vectors 
pSV2i-Hindlll and pRSVi-HindIl] (generously provided by Drs. B. Forman 
and H.  Samuels, New York University Medical Center, New York). The 
resulting expression vectors, pSV2i-GFA and pRSVi-GFA, were amplified 
in HB10L 
Cell Culture 
Mouse L tk- cells were cultured in DME containing 10% FBS,  100 U/mi 
penicillin, and 100 #g/ml streptomycin sulfate (GIBCO BRL, Gaithersburg, 
MD) and maintained in a 37°C incubator under 7% CO2 and 80% humid- 
ity.  Human astrocytoma cell line, U251MG, a kind gift of Dr. B. Wester- 
mark  (University of Uppsala,  Uppsala,  Sweden)  was cultured in DME 
containing  10%  heat-inactivated FBS,  100 U/ml  penicillin,  100 t~g/ml 
streptomycin sulfate,  1%  non-essential amino acid and maintained in a 
37°C incubator under 7% CO2 and 80% humidity. AS2-U251 cells whose 
endogenous GFAP had been suppressed by constitutive expression of the 
anti-sense strand of murine GFAP cDNA (Weinstein et al., 1991) were cul- 
tured under the same conditions as the parent cell line, U251MG, except 
that 500 #g/ml G418 (G-eneticin, GIBCO BRL) was added to their media. 
In the case of the rescue experiments in which AS2-U251 cells were stably 
co-transfected with GFAP-expression vectors and the Hygromycin-resis- 
tance gene, 300 ~tg/mi  Hygromycin B  (Sigma Chemical Co.,  St. Louis, 
MO) was added in addition to 500 #g/ml G418. 
Transient Transfections 
The transient transfection protocol  using  lipofectin  (GIBCO  BRL)  was 
modified from that described by Feigner and Ringold (1989). Briefly,  cells 
were  grown to 70-80%  confluence in 35-mm tissue culture plates  and 
washed twice with calcium- and magnesium-free PBS (CM-PBS), and once 
with serum-free media. 0.5 mi of a lipofectin-DNA mixture, consisting of 
a mixture of 5-10 #g pRSVi-GFA DNA or pSV2i-GFA DNA and 5-15 ;tg 
of lipofectin diluted in 0.5 ml of serum-free culture medium, was then added 
to each plate. After incubation at 37°C for 3-5 h, an additional 0.5 ml of 
serum-free medium was added to each plate. The medium was replaced 
6-12 h later with 2 ml culture medium containing 10% FBS, and aliquots 
of the cells were examined during the next 24-72 h. 
Stable Transfections 
Stable transfections were performed using the same procedures described 
for  the  transient  transfactions  except  that,  after  the  cultures  became 
confluent in 35 nun plates, they were split onto two 100 mm tissue culture 
plates and grown in the appropriate selection medium (i.e.,  G418 for L 
tk- cells and G418 plus Hygromycin B for the stable transfections of AS2- 
U251 cells). The corresponding antibiotic resistance genes, pSV2-Nee and 
pUC-Hyg  1.1, were co-transfected with either pRSVi-GFA or pSV2i-GFA 
in a 1:10-20 (wt/wt) ratio. The pUC-Hyg 1.1 vector is a kind gift from Dr. 
T. M.  DeChiara (Columbia University). 
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Unless otherwise specified, all immunocytochemical experiments were per- 
formed in Lab-Tek eight-well tissue culture slides (Miles Laboratories, Inc., 
Naperville, IL) coated with 50 ng/ml poly-L-lysine (Sigma Chemical Co.). 
About  1  ×  104 cells suspended in 0.2-0.4 ml of culture medium were 
added to each well and incubated at 37°C in 7% CO2 at controlled humid- 
ity for 24-48 h. Cells were fixed in ice cold methanol for 7 rain and then 
washed with CM-PBS. Nonspecific  binding was blocked by incubation with 
5 % laBS, diluted in CM-PBS, for 30 rain at room temperature. The blocking 
solution was replaced with polyclonal rabbit anti-GFAP antibody, diluted 
1:200 in CM-PBS, and incubated for 1 h at room temperature. After wash- 
ing with CM-PBS and incubating with fluorescein (FITC)-conjugated or 
rhodamine (TRITC)-conjugnted goat anti-rabbit immunoglobulin, diluted 
1:300 in CM-PBS, for 20 min at room temperature, the slides were mounted 
in a  mixture of 16%  polyvinyl alcohol (Sigma Chemical Co.) and 33% 
glycerol in CM-PBS, and examined with a  Nikon Optiphot microscope 
equipped for epifluorescence. In the case of co-culture experiments, the 
same immunostaining protocol was followed except that pAb-MAP4 and 
G-A-5 were used as primary antibodies and FITC-labeled goat anti-mouse 
IgG and TRITC-labeled goat anti-rabbit IgG antiserum as secondary anti- 
bodies. In experiments where the length and number of the processes were 
measured,  we recorded the immunostained cultures with a  Silicon In- 
tensified Target  Camera (65 series; Dage-MTI, Inc., Michigan City, IN) 
and digitized them with an Image-I image analysis program (Universal Im- 
age Corp., West Chester, PA). 
Western Blot Analysis 
Preparation of cytoskeletal proteins and Western blotting were performed 
as described (Ching and Liem, 1993),  except that 10% SDS-PAGE at a pH 
of 9.2 was used to enhance the mobility difference between human and rat 
GFAP. Monocional anIi-GFAP antibody, G-A-5, diluted 1:400 in PBS was 
used as primary antibody and 125I-labeled goat anti-mouse IgG (New En- 
gland Nuclear) was used as secondary antibody. The blot was exposed with 
intensifying screen for 8 h at -80°C using Kodak XAR-5 Scientific Imaging 
Film. Densitometric scanning was done using an Apple OneScanner with 
Ofoto scanning software (Apple Comp. Inc., Cupertino, CA) and analyzed 
by NIH Image 1.43 Gel Analysis program (National Institutes of Health, 
Bethesda, MD). 
RNase Protection Analysis 
Total  cellular  RNA  was  isolated  following the  protocol  described by 
Chomczynski et al.  (1987).  pGEM7Zf-G92 was digested with ApaI and 
religated to form pGEM7Zf-G92(ApaI) which included the entire protein 
coding region and 12 nncleotides beyond the termination codon. Antisense 
riboprobes  of  rat  GFAP  were  transcribed  by  T7  polymerase  using 
pGEM7Zf-G92(ApaI) as template and labeled with [~-32p]CTP  following 
the protocol described by Melton et al. (1984).  The entire coding region 
of the human GFAP was synthesized by PCR (Chen and Liem, 1994) and 
cloned into the unique HindIII site of pGEM3Z.  The resulting plasmid 
pGEM3Z-hGF was transcribed by SP6 polymerase to make the antisense 
riboprobe of human GFAP. RNase protection analyses were modified from 
protocols described by Ching and Liem (1991). Briefly, 20/~g of total RNA 
was hybridized with 5  x  105 cpm of appropriate riboprobes in 30 t~l of 
hybridization buffer (80% formamide, 40 mM Pipes (pH 6.7), 0.4 M NaCI, 
and 1 mM EDTA). After incubations at 85°C for 5 rain and subsequently 
at 45"C overnight, 300 tA of RNase digestion buffer (10 mM Tris-HCl, pH 
7.5,  5 mM EDTA, and 200 mM sodium acetate) plus 15 U RNase ONE 
(Promega Biotec) was added to the hybridization mixture and incubated at 
30°C for 60 min. The activity of RNase ONE was irreversibly inactivated 
by the addition of 5 ~1 of 10%  SDS containing 4 t~g/tA of carrier tRNA. 
The  protected RNAs were isolated by ethanol precipitation and  subse- 
quently resuspended in 10 ~1 of loading buffer (80% formamide, 10 mM 
EDTA, 0.1% bromophenol blue, 0.1% xylene cyanol, and 0.1% SDS). The 
samples were resolved on a 6% polyacrylamide/8 M urea gel. Autoradiog- 
raphy was performed by exposing the gel to Kodak XAR-5 film at -70"C 
with an enhancing screen. 
Co-culture Experiment 
Co-culture experiments with postnatal day 3 to day 5 rat cerebellar granule 
neurons were performed as described by Weinstein et al. (1991) except that 
neurons were added to astrocytic cells in a  ratio of 60--100:1  to saturate 
potentially responsive cells. 
Process Measurement 
A process was defined as any protrusion with a tipped end and a base whose 
width was shorter than the length of the protruding part. The length of the 
entire process, however, was defined as the distance from the geometric cen- 
ter of the nucleus of the cell to the very end of process. At least 55 cells 
were systematically picked for measurement of process length and number. 
The results were expressed  :as average process number and length per cell. 
To minimize the effect of variability between cell lines, the percentages of 
increase or decrease of process length and number in the presence and ab- 
sence of neurons were determined separately for each cell line. 
Results 
Characterization  of a Fully Encoding Rat GFAP 
cDNA Clone 
A 2.7-kb GFAP eDNA clone, G92, was isolated from a rat 
brain 3,-gtl 1 cDNA library by high-stringency DNA hybrid- 
ization with a fragment of  mouse GFAP eDNA (Lewis et al., 
1984) and was subsequently subcloned into pGEM-7Zf. The 
GFAP cDNA insert was further subeloned in both orienta- 
tions into M13mpl8 for sequencing. Comparison with the 
published rat GFAP sequence (Feinstein et al., 1992),  indi- 
cated that the insert was full-length, containing the entire 
coding  and  3'-untranslated  regions.  Our  nucleotide  se- 
quence, however, is not completely identical to the published 
sequence (available  from EMBL/Genbank/DDBJ under ac- 
cession number L27219). Nevertheless, most of the differ- 
ences were located in the 3'-untranslated region. Although 
two discordant nucleotides were present in the coding re- 
gion, they did not change the predicted amino acid sequence. 
The rat GFAP amino acid sequence showed a high degree 
of homology with those of human and mouse GFAP. The 
differences are mainly in the head domain while the tail do- 
mains are highly conserved. Even with these high overall ho- 
mologies, rat GFAP has a lower mobility on SDS-PAGE, by 
"~2-3 kD, than either human or mouse GFAP (Liem et al., 
1978;  and Fig. 2). 
Further evidence that the G92 cDNA clone is fully encod- 
ing for rat GFAP was obtained by in vitro transcription/ 
translation after subcloning the GFAP eDNA into pGEM- 
7Zf. RNA transcripts were generated from either the T7 or 
SP6 promoter and subsequently translated in vitro in a rabbit 
reticulocyte lysate system. Products of in vitro transcription 
and translation of  clone G92 were analyzed on an SDS-PAGE 
gel, resulting in a band of about 50 kD when the SP6 pro- 
moter was used (data not shown). 
Transient and Stable Transfections  of  L tk- Cells Show 
GFAP-positive l~lamentous Networks 
Two  eukaryotic  expression  vectors,  pRSVi-HindIII  and 
pSV2i-HindIII, were used to express rat GFAP eDNA in cul- 
tured  cells.  Clone G92  GFAP eDNA  was  isolated from 
pGEM-G92 and subeloned into the unique HindIII sites in 
these  vectors.  The  resulting  constructs,  pRSVi-GFA and 
pSV2i-GFA, were first tested for eukaryotic cell expression 
by transient transfections into L tk- cells. Stable transfec- 
tions were performed by co-transfection with pSV2-Neo and 
selection with the neomycin analog G418.  G418-resistant 
clones were isolated and studied for GFAP expression. All 
of these stably transfected fibroblasts showed GFAP-posi- 
tive, filamentous networks reminiscent of those observed in 
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rat GFAP co-localized with the endogenous vimentin net- 
work and did not cause significant changes in the morphol- 
ogy of the cells, especially in terms of the quality and quan- 
tity  of  the  processes  of  these  fibroblasts  which  is  best 
demonstrated by the results of transient transfection experi- 
ment (Fig.  1, B  and C). 
Transient and Stable Transfections of  AS2-U251 
Cells Result in the Reexpression  of  a l~lamentous 
GFAP  Network 
Both pRSVi-GFA  and  pSV2i-GFA  were used  to transfect 
AS2-U251  cells,  the  GFAP-suppressed  cell  lines  derived 
from the human astrocytoma ceils, U251MG (Weinstein et 
al.,  1991).  Transient transfections of either construct into 
AS2-U251  cells  resulted  in  a  GFAP(+)  filamentous  net- 
work.  The AS2-U251  lines were obtained by transfection 
with  an  expression  construct  which  constitutively  tran- 
scribed the anti-sense strand of mouse GFAP eDNA and a 
neomycin resistance  selectable  marker  (Weinstein  et  al., 
1991). The isolation of stable AS2-U251 cell lines reexpress- 
ing GFAP therefore required a second selectable marker, for 
which  we  used  hygromycin-resistance.  Plasmids  carrying 
the  hygromycin-resistance  gene,  pUC-Hyg  1.1, were  co- 
transfected with either pRSVi-GFA or pSV2i-GFA in a ratio 
of 1:20. A  number of AS2-U251  transfectants which were 
resistant to both neomycin and hygromycin and stained posi- 
tive for GFAP were isolated. Previous studies had shown that 
there was a difference in gel mobility between human and rat 
GFAP. To find out whether these cell lines were expressing 
exogenous rat GFAP or reexpressing human GFAP, we iso- 
lated  the  Triton-insoluble  cytoskeletal  fraction  from four 
stably  transfected  clones,  ASH3B7E,  ASH3DTE,  ARH- 
2B8E, and ARH4B9C and studied their GFAP composition 
by  SDS-PAGE  and  Western  blot  analysis.  The  Triton- 
insoluble cytoskeletal fractions from these clones contained 
only a  single,  GFAP(+)  band whose mobility was slower 
than that of human GFAP (Fig.  2).  To further substantiate 
the expression of transfected rat GFAP, total cellular RNA 
of  these  stably  transfected  clones  as  well  as  those  of 
U251MG and one of the stably transfected L tk- cell lines, 
GR1D6G4, were isolated for RNase protection analyses. As 
shown in Fig.  3,  all four rescued cell lines and the stably 
Figure 1. Transfected rat GFAP in L tk- cells formed filamentous 
networks reminiscent of those in astrocytic cells.  (A) pSV2i-GFA 
was stably transfected into L tk- cells.  A representative  stable L 
tk- transfectant was stained with polyclonal anti-GFAP antiserum 
to demonstrate the filamentous networks of rat GFAP. (B and C) 
The expression of rat GFAP in L tk- cells did not change their 
morphology significantly as demonstrated in the transient transfec- 
tion experiment which were stained with polyclonal anti-GFAP an- 
tisernm (B) and monoctonal anti-vimentin antibody (C). Also no- 
tice  that  GFAP  staining  co-localizes  with  the  staining  of the 
endogenous vimentin.  Bar, 25 #M. 
Figure 2.  The  GFAP  reex- 
pressing  stable  cell  lines 
contained  only  rat  GFAE 
Triton-insoluble  fraction  of 
cytoskeletal protein from four 
GFAP reexpressing stable cell 
lines,  ASH3D7E  (lane  1), 
ASH3B7E (lane 2), ARH2BSE 
(lane  3),  and  ARH4B9C 
(lane 4) were isolated.  Equal 
amounts  of  pelleted  protein 
were  loaded  on  a  10%,  pH 
9.2,  SDS-PAGE, and  trans- 
ferred overnight to nitrocellu- 
lose paper. Monoclonal anti-GFAP antibody and t:SI-labeled goat 
anti-mouse Ig were used to demonstrate their GFAP content.  All 
four lines showed a single band with a mobility slower than that of 
human GFAP from the U251MG cells (lane 5). 
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fully protected by the antisense riboprobe of rat GFAP.  The 
ARH2B8E cells expressed a  second band which may be a 
truncated rat GFAP mRNA resulting from random integra- 
tion.  In contrast,  total cellular RNA from U251MG  cells 
showed only small, discontinuous,  protected bands as pre- 
dicted  from the  inter-species  differences between the  two 
mRNAs. These bands were missing from the four rescued 
cell lines indicating that human GFAP mRNA was not reex- 
pressed in these cells. When RNase protection analyses were 
done with antisense riboprobe of human GFAP, only the to- 
tal cellular RNA from U251MG cells contain a  fully pro- 
tected band (not shown). Since neither human GFAP mRNA 
nor its protein product was detectable in the four rescued cell 
lines, we can rule out the possibility that these clones were 
revertants. 
The Reexpression of GFAP in AS2-U2M 
Cells Rescues Their Ability to Form Processes in the 
Presence of Neurons 
Previous  studies  from  our  laboratory  showed  that  when 
GFAP expression is suppressed by means of an anti-sense 
construct, the resulting mutant U251 cells cannot extend sta- 
ble processes in response to the addition of neurons. If the 
suppression of GFAP expression is the sole reason for this 
loss of function, we should be able to restore it by reexpress- 
ing GFAP in these cells. We tested the four cell lines in which 
GFAP had been reexpressed for their ability to respond to 
the addition of neurons. Fig. 4  shows an example of one of 
these rescued cell lines co-cultured with primary cerebellar 
neurons. Also apparent in Fig. 4 is the exact co-localiTation 
of GFAP and MAP4 staining (Fig. 4, A and B, respectively), 
which justified our use of the primate-specific anti-MAP4 
antiserum to stain the rescued cell lines.  As illustrated in 
Fig. 5, the rescued cell lines put out long slender processes 
comparable to U251MG cells in response to neuronal con- 
tact (cf. Fig. 5, B and E), while AS2-U251 cells did not show 
significant process formation under similar conditions (Fig. 
Figure 3. RNase protection analyses of total cellular RNA of the 
rescued cell lines shows the presence of rat GFAP mRNA and the 
absence of human GFAP mRNA. 10 #g of total cellular RNA from 
ASH3B7E  (lane  1),  ASH3D7E  (lane  2),  ARtt2B8E  (lane  3), 
ARH4B9C (lane 4), U251MG (lane U), GR1D6G4 (lane L) were 
hybridized with a  1.3-kb antisense riboprobe  which contains  se- 
quence complementary to the position  1 to 1306 of the rat GFAP 
mRNA. Lane P  is the antisense  rihoprobe  which is transcribed 
from HindIII-linearized pGEM7Zf-G92(ApaI)  using T7 polymer- 
ase. Lane M is HaelII-digested  ¢bX174 DNA marker labeled with 
Klenow  DNA  polymerase and  [ot-32p]dCTP. The  markers are 
1353-, 1078-, 872-, 603-, 310-, and 28-bp long. All the rescued cell 
lines along with the stably transfected L tk- cell lines, GRID6G4, 
showed a band fully protected by the antisense riboprobe. This band 
is absent in the human U251MG ceils which showed a number of 
smaller bands not found in the rescued cell lines. 
Figure 4. The morphological changes of GFAP re.expressing cells 
in the presence of neurons. The co-culture experiment of one of the 
rescued cell lines, ASH3BTE, with primary granule cells from neo- 
natal  rat cerebellum  is shown here.  The cultures  were fixed and 
stained with polyclonal anti-MAP4 antiserum (A) and monoclonal 
anti-GFAP antibody, (B), to demonstrate the exact co-distribution 
of these two proteins.  Bar, 50/~M. 
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in response to neuronal contact, pSV2i-GFA and pRSVi-GFA were stably transfccted into GFAP-suppressed AS2-U251 cells. The resulting 
stable cell lines were co-cultur~ with primary granule cells from neonatal rat cerebellum. As demonstrated in E and F, the reexpression 
of rat GFAP in AS2-U251 cells resulted in longer, stable processes in response to neuronal contact as compared to parental AS2-U251 
ceils (Hand I). A, D, and G represent, respectively, U251MG, ASH3B7E, one of the rescued cell lines, and AHG1A7D, the vector-control 
cell line, when they were cultured alone. B, E, and H illustrate their morphological change when they were co-cultured with neurons, 
respectively. A through H, excluding C and F,, were stained with primate-specific polyclonal anti-antiserum. C, F, and I are phase contrast 
pictures of B, E, and H to show normal neurite outgrowth of the co-cultured rat cerebellar neurons under all three conditions. Bar, 50 #M. 
5 H). Most of the responding cells had a morphology inter- 
mediate between Bergmann-like and steUate forms. However 
in some local areas, the responding cells displayed relatively 
complex  processes  and  obtained  a  stellate  morphology 
(results  not  shown).  The  immunofluorescent  images  were 
digitized and analyzed with the Image-1 image analysis soft- 
ware. The average process length and number per cell were 
measured in the presence and absence of neurons.  To avoid 
counting primary rat brain astrocytes, primate-specific poly- 
clonal anti-MAP4 antiserum was used for immunostalning. 
As shown in Fig. 4, there was a co-distribution of MAP4 and 
GFAP and they both reached the very tip of the extending 
processes.  As  a  consequence,  we  could  stain  cells  with 
anti-MAP4  antibody  without  losing  fidelity  of their  pro- 
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Neuron  (-)  Neuron (+)  Percentage  of increase 
Relative 
GFAP  Average  Average  Average  Average  Process  Process 
Cell lines  content*  Process Length  Process  Number  Process Length  Process Number  Length  Number 
ASH3D7E  120  22.79*  0.67  75.89*  2.04  233  204 
ASH3B7E  95  19.60  0.62  74.10  1.91  278  209 
ARH2B8E  68  49.77  1.15  129.26  1.78  160  55 
ARH4B9C  131  31.38  0.69  130.04  2.24  314  224 
AS2  0  33.38  0.80  49.87  0.88  49  9 
AHG1A7D  0  41.67  1.04  69.11  1.54  66  48 
U251  100  27.97  0.43  89.48  1.62  222  275 
The GFAP reexpressing cell lines regained the ability to extend stable processes in the presence of neurons to a degree comparable to U251MG cells. The average 
process number and length per cell in the presence and absence of neurons were analyzed for four GFAP reexpressing cell lines. The percentage of increase of 
either process number or process length with the addition of neurons was used to compare between these cell lines and controls to avoid inter-cell line variability. 
Process  measurements performed  as described  in Materials and Methods. 
* The GFAP content in each cell line is compared to U251 whose GFAP content is arbitarily designated as  100. 
The unit of process  length is t~m. 
Figure 6. The GFAP  reexpressing cell lines put out more and longer 
processes when co-cultured with neurons.  The  immunotluores- 
cence image of the four rescued cell lines, ASH3D7E, ASH3B7E, 
ARH2BSE, and ARH4B9C, two negative-control cell lines, AS2- 
U251 and AHGIA7D, and a positive-control cell line, U251MG in 
the presence or absence of granule cells of neonatal rat cerebellum 
were analyzed as described in Materials and Methods. The average 
process length and process number per astrocytoma cell in the pres- 
ence of neurons were compared to those in their absence. The per- 
centages of increase thus obtained (see Table I) were plotted against 
their relative GFAP content in respect to U251MG cells. All four 
rescued cell lines increase their process length to a degree compara- 
ble to U251MG in the presence of neurons. Excluding ARH2BSE, 
cesses,  both qualitatively and quantitatively.  All cell lines 
examined, including AS2-U251 and the vector-control cell 
line AHGIATD, showed increases in process length when co- 
cultured with neurons.  To avoid the inherent variations in 
process  formation capabilities  among the  transfected  cell 
lines,  we compared percentages of increase upon addition of 
neurons rather than the raw numbers.  The percentages of 
process length increase obtained for the rescued cell lines 
varied from 160 to 314% (Table I). In comparison, the per- 
centages of increase  in  process length  of AS2-U251  and 
AHG1A7D cells were 49 and 66%, respectively.  Therefore, 
all  four  GFAP  reexpressing  cell  lines  extended  longer 
processes in response to neurons than either AS2-U251 or 
control AHG1A7D cells.  The percentage of process length 
increase displayed by the GFAP reexpressing lines was also 
comparable to that of the parental, untransfected U251MG 
cells (220 %). A correlation between the amount of  GFAP ex- 
pressed and the length of the processes was also observed 
(Fig. 6). The average process number per cell of these GFAP 
reexpressing lines also increased in the presence of neurons 
(Table I, and Fig. 6). However,  ARH2B8E did not show an 
increase in process number comparable to the other three 
GFAP reexpressing cell lines.  Collectively, we conclude that 
three of the four lines tested completely regained the ability 
to extend processes in response to neurons. 
Discussion 
Although intermediate filament proteins show a cell type- 
specific distribution, no cell type-specific functions have as 
yet been directly demonstrated for most of these proteins. 
Several lines  of evidence indicate that GFAP should have 
such  a  specific  function.  Firstly,  astrocytes  in  different 
regions of the adult central nervous system contain different 
their average process number per cell also increased to a degree 
comparable to U251MG. There seemed to be a correlation between 
the amount of GFAP and the ability to extend longer processes but 
the process number increase did not correlate well with GFAP 
amount. 
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al.,  1985).  Protoplasmic astrocytes in gray matter, which 
normally contain little GFAP, accumulate the protein rapidly 
in response to a variety of insults (Bignami and Dalai,  1976; 
Amaducci et al.,  1981; Goldmuntz et al.,  1986; Smith and 
Eng,  1987;  Smith et al.,  1983). Secondly, GFAP has been 
found to accumulate during postnatal brain development in 
parallel with the transition from a motile to a non-motile cell 
in culture (Fedoroff, 1986; Kalnins et al.,  1984). Thirdly, a 
transient elevation in both GFAP mRNA and immunoreac- 
tivity which corresponds to the proliferation and differentia- 
tion of interfascicular glia occurs after cessation of axon in- 
growth  (Schnitzer  et  al.,  1981)  and  during  initiation  of 
myelination in the white matter of postnatal mouse cerebel- 
lum (Bovolenta et al.,  1984). Fourthly, Bergmann fibers in 
the developing mouse cerebellum are stained positive for 
vimentin at El9 and become GFAP immunoreactive after the 
first postnatal week when granule ceils of  the external granu- 
lar layer start to migrate inward (Bovolenta et al.,  1984). 
Similar findings that GFAP(+) ceils appeared at the time of 
glial-guided migration were reported in the hippocampus 
and other regions of the developing rodent brain (Gasser and 
Hatten,  1990a; Mason and Gregory, 1984). 
Finally,  the suppression of GFAP expression in human 
U251MG astrocytoma cells caused the loss of the ability of 
these cells to form stable complex processes in the presence 
of granule neurons (Weinstein et al.,  1991).  Since the ex- 
pression of  vimentin and other cytoskeletal elements in these 
AS2-U251 cells were not affected, this result was the first di- 
rect evidence that GFAP has a unique role in the process ex- 
tension of these astrocytic cells. 
To establish with greater certainty that the inability of the 
GFAP-suppressed ceils  was  solely due to the  absence of 
GFAP, we set out to rescue the ability of  these cells to extend 
stable processes by expressing rat GFAP in these cell lines. 
We used rat GFAP instead of human GFAP in order to rule 
out the possibility of wild type revertants, which would ex- 
press human GFAP. Toward this end, we screened a rat brain 
cDNA library and obtained a fully encoding rat GFAP eDNA 
which included the entire 3'-untranslated region. This clone 
was  transfected into  the  GFAP-suppressed AS2-U251MG 
cell lines previously created in our laboratory. The results 
showed that not only did a GFAP-containing filamentous net- 
work re-appear, but process formation in response to neu- 
rons was restored. 
Four  stable  transfeetants  were  randomly  selected  and 
tested for their process extending ability in the presence of 
granule neurons. The degree of response varied among these 
isolates. All four responded as well or better than U251MG 
cells when average increases in process length were com- 
pared.  However, one isolate, ARH2B8E, failed to show a 
significant response in terms of increases in process number 
to neuronal stimulation.  Taking into account the fact that 
these rescued cell lines had gone through two stable transfec- 
tion events and were over-expressing three foreign proteins, 
rat GFAP,  aminoglycoside phosphotransferase, and hygro- 
mycin B phosphotransferase, it is possible that one of  the sta- 
ble transfectant lines did not fully regain the ability to extend 
processes in response to the contact of neurons. We believe 
that these results further substantiate the role of GFAP in 
true process extension of these astrocytoma cells when they 
are co-cultured with granule neurons of rodent cerebellum. 
As shown in Fig. 6 and Table I, these rescued cell lines 
also expressed different amounts of GFAP.  Although there 
was  no  linear  correlation between  the  amount  of GFAP 
expressed and  the  degree of process extension,  the  high 
amount of GFAP in one cell line,  ARH4B9C,  seemed to 
be correlated to its  better ability  to extend processes in 
the presence of neurons and,  in contrast,  the poorest re- 
sponding cell line, ARH2B8E, expressed the lowest amount 
of GFAP. 
The  AS2-U251  cells  were  created  by  transfecting  the 
antisense-strand of the protein coding region of the mouse 
GFAP into the U251MG cells. To overcome the effect of an- 
tisense  mRNA  and  reexpress  GFAP  in  these  AS2-U251 
ceils, we over-expressed the sense strand of rat GFAP by the 
same strong, constitutive promoter that was used to drive the 
expression of  antisense mRNA, which may be one of  the rea- 
sons  why  our  rescued cell  lines  showed  only  rat  GFAP 
mRNA without detectable amounts of the endogenous hu- 
man GFAP mRNA. 
We were also concerned about the non-specific effects of 
any exogenous oligonucleotide. As has been pointed out by 
Woolf et al. (1992), the shortest sequence that is likely to be 
unique within the mRNA pool is 13 bases. In other words, 
any sequence less than 13 bases in length is expected to occur 
more than once in the mRNA  pool.  Any oligonucleotide 
longer than 13 bases will contain more than one consecutive 
12 mer and hybridize with more species of mRNA. There- 
fore, any antisense oligonucleotide designed for a particular 
mRNA  is  expected to have non-specific effects on other 
unrelated mRNAs.  By this argument,  a  constitutively ex- 
pressed antisense mRNA such as the one we used in AS2- 
U251  cells which contains more than one thousand con- 
secutive  12  mers  could result  in  a  thousand times more 
non-specific effects. However, it is clear that the longer the 
sequence of the antisense mRNA, the less chance there is to 
find a  unrelated mRNA  with more than  10%  fully com- 
plementary sequence in the mRNA pool. As a consequence, 
the melting temperature between these two species of  mRNA 
may be so low that any significant hybrid formation between 
the two mRNAs will not exist at the physiological tempera- 
ture of the cell. In addition, living cells renew their mRNA 
constantly.  Compared  to  the  specific  effect of antisense 
mRNA,  the insignificant non-specific effect on other un- 
related mRNAs will be further minimized by the cellular 
renewal  of these mRNAs.  Nevertheless,  the  non-specific 
effect of antisense mRNA cannot be ruled out completely. 
Therefore, be it unlikely, there remains a possibility that the 
mRNA pool of AS2-U251 may have been disturbed by the 
non-specific effects of the antisense mouse GFAP mRNA 
and the transfection of sense strand rat GFAP mRNA may 
have titrated out these non-specific suppressions  and re- 
suited in the rescue of the phenotype. This possibility is 
deemed even more unlikely since the transfection of the rat 
GFAP failed to unblock the specific suppression of human 
GFAP mRNA. 
Two different forms of glia have been described in early 
postnatal mouse cerebellum: stellate and elongated, Berg- 
mann-like glia (Hatten et al., 1984). These two cell types in- 
teract differently with neurons.  The stellate forms usually 
associate with several dozen neuronal cells while the elon- 
gated, Bergmann-like glia react with two to three neurons. 
In vitro studies with either hippocampal or cerebellar neu- 
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gated  Bergmann-like  glial  profiles  (Gasser  and  Hatten, 
1990a; Hatten et al., 1984).  Although in the co-culture ex- 
periments of primary astrocytes and granule neurons, most 
astrocytes had a stellate profile (Hatten et al.,  1984),  pure 
stellate forms are uncommon in our rescued cell lines. Most 
of our responding cells are intermediate between Bergmann- 
like and stellate cells, with one prominent, elongated process 
accompanied by one or two shorter processes.  These are 
closer in morphology to the bipolar form of astroglia in cul- 
tures derived from the developing rat hippocampus (Gasser 
and Hatten, 1990a). According to the study of Misson et al. 
(1991) on murine cerebral cortex, this form of  astroglia is on- 
togenically earlier than the other forms. This may be related 
to the de-differentiated state of these astrocytoma-derived 
cell lines. 
Process formation involves many phases of interaction but 
can roughly be separated into three phases: initiation, elon- 
gation, and consolidation/stabilization (Alleta and Greene, 
1988;  Goldberg and Burmeister,  1992;  Teng and Greene, 
1993).  Actin  networks  and  their  associated  proteins  ap- 
peared to be involved in initiation (Fedoroff et al.,  1987; 
Goldman and Abramson, 1990) while the extracellular ma- 
trix and membranous proteins play a major part in leading, 
guiding and ending a process in extension phase (Mason et 
al., 1988; Streit et al., 1993; Stitt and Hatten, 1990; Antoni- 
cek et al., 1987), Besides contact with live neurons (Hatten, 
1985;  Hatten,  1987; Weinstein et al.,  1990, 1991), cAMP 
analogues such as dibutyryl cAMP (Goldman and Abramson, 
1990;  Goldman  and  Chiu,  1984;  Messens  and  Slegers, 
1992;  Fedoroff et al.,  1987),  brain  extract (Pollenz and 
McCarthy, 1986; Lira et al., 1973), phorbol ester (Harrison 
and Mobley,  1990),  cytochalasin B (Baorta et al.,  1992), 
prostaglandins  (Tardy  et  al.,  1981), lipopolysaccharide 
(Messens and Slegers, 1992), and hormonal stimulus (Choi 
and Lapham, 1978) have all been reported to induce astro- 
cytes or astrocytoma cell process formation. Among them, 
agents or factors expected to increase intracellular cAMP 
such as dibutyryl cAMP, forskolin (Pollenz and McCarthy, 
1986; Shalit-Zagardo et al., 1988), and B-receptor agonists 
(Browning and Ruina, 1984; McCarthy et al., 1985; Murphy 
and Pearce, 1987; Shain et al., 1987) have more consistent 
effects on cell morphology. GFAP protein (Backhovens et 
al., 1987; Goldman and Chiu, 1984;  Messens and Slegers, 
1992) and mRNA (Shafit-Zagardo et al., 1988; Messens and 
Slegers,  1992) in these astrocytes or astrocytoma cells are 
usually elevated in response to increased intracellular cAMP 
and increased phosphorylation of GFAP and vimentin is a 
consistent finding preceding either cAMP- or phorbol es- 
ter-induced changes in astrocyte morphology (Pollenz and 
McCarthy, 1986; Baorta et al., 1992; Harrison and Mobley, 
1990), indicating that there could be a role for IF's in the for- 
mation  of these  processes.  However,  it  is  unlikely  that 
changes of IF's, including their synthesis and posttransla- 
tional modification such as phosphorylation, are involved in 
process initiation because astrocyte process formation can be 
dissociated from these changes of IFs (Pollenz and McCar- 
thy,  1986;  Baorta et al.,  1992). 
Our data argue that GFAP is an indispensable part of the 
formation of stable processes of U251  astrocytoma cells in 
response to neuronal contact, since the suppression of GFAP 
led to a decrease in process formation and its reexpression 
rescued this phenomenon.  However,  both the GFAP-sup- 
pressed  AS2-U251  cells and the vector-only control cell 
line, AHG1A7D, showed some degree of process formation 
in response to neuronal contact (Table I and Fig. 6). Given 
that IFs may not be required for initiation, one explanation 
could be that the other cytoskeletal elements, such as micro- 
tubules and microfilarnents, are capable of initiating and ex- 
tending processes in response to the neuronal stimuli but 
cannot stabilize these processes  in the absence of GFAP. 
Most  likely,  the  processes  are  constantly extending  and 
retracting and GFAP is required to stabilize the processes, 
rendering them more resistant to retractions (Fedoroff  et al., 
1987; Duffy, 1983).  Although these results argue for a role 
of GFAP in the stabilization of astrocytic processes in cul- 
tured cells, we have to be careful in extending this conclusion 
to a  real in vivo situation, since similar conclusions were 
made for the role of the microtubule associated protein, tan, 
in the formation of axonal processes in primary neurons in 
culture (Caceres and Kosik,  1990).  Cerebellar neurons in 
dissociated culture become polarized and extend character- 
istic single, axonlike neurites after a relatively constant in- 
terval.  By  selectively inhibiting tau  expression  with  an- 
tisense oligonucleotides, the elaboration of axonlike neurites 
was significantly suppressed.  Since the initial exploratory 
neurite formation was not affected, tan seemed to play an in- 
dispensable role in the conversion (stabilization) phase ofax- 
onal development. In contrast, gene targeting studies showed 
that the nervous system of tau-deficient mice appeared to be 
normal immunohistologically  and axonal elongation was not 
affected in cultures of primary neurons from these mice 
(Harada et al., 1994). These results dearly indicate that tau 
is dispensable for axonal elongation in vivo.  Similar con- 
tradictions  between  the  results  of antisense  suppression 
studies and those of transgenic knockout studies have also 
been reported in another system (Sariola et al., 1991; Lee et 
al., 1992). Our conclusions about the role of GFAP in astro- 
cytic process  formation in  vivo must therefore await the 
results of specific gene targeting studies in transgenic mice. 
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